The classical MAPK pathway, specifically the RAF/MEK/ERK cascade, is one of the most commonly disrupted pathways in cancer, leading to increased cell growth and decreased apoptosis [23], which adds another layer of complexity by functioning as a negative regulator of the RAS/MAPK pathway. This evidence concerns the gene MAPK1 and cancer.